Om Sam
Family Medicine · Sullivan, MONPI 1457845588
Payments from drug & device makers
Across 188 payments — averaging $16.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$314
- Novo Nordisk$301
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$258
- Novartis$231
- Lilly USA, LLC$208
- Merck$208
- plus $2K from 25 others
What the payments were for
- Food & beverage$3,071100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 30 | $314 |
| Novo Nordisk | 16 | $301 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 18 | $258 |
| Novartis | 11 | $231 |
| Lilly USA, LLC | 11 | $208 |
| Merck | 15 | $208 |
| Amgen | 10 | $163 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $157 |
| AstraZeneca | 9 | $141 |
| Dexcom, Inc. | 6 | $111 |
| Johnson & Johnson | 6 | $110 |
| AbbVie | 6 | $104 |
| Bayer | 6 | $102 |
| Exact Sciences | 5 | $91 |
| Edwards Lifesciences | 4 | $82 |
| Lundbeck LLC | 4 | $81 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $54 |
| Sobi, Inc | 2 | $42 |
| Pfizer | 3 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| Valinor Pharma, LLC | 2 | $30 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Ironwood Pharmaceuticals, Inc | 1 | $20 |
| Abiomed | 1 | $20 |
| Bristol Myers Squibb | 1 | $20 |
| Shield Therapeutics Inc | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
| Convatec Inc. | 1 | $12 |
| Sumitomo Pharma America, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$103
How this compares
$3,071 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 58 | $45,580 |
| OzempicSemaglutide | 27 | $38,581 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 55 | $38,348 |
| EliquisApixaban | 27 | $30,474 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 43 | $22,299 |
| FarxigaDapagliflozin Propanediol | 25 | $21,962 |
| TrulicityDulaglutide | 12 | $11,069 |
| DuleraMometasone/Formoterol | 21 | $7,088 |
| BrilintaTicagrelor | 11 | $4,876 |
| Qvar RedihalerBeclomethasone Dipropionate | 17 | $4,221 |
| Atorvastatin Calcium | 262 | $2,124 |
| Omeprazole | 105 | $1,795 |
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 12 | $1,513 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 78 | $1,337 |
| Gabapentin | 66 | $1,218 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $314 | $60,64798 claims |
| Novo NordiskOzempic | $301 | $38,58127 claims |
| PfizerEliquis | $42 | $30,47427 claims |
| AstraZenecaFarxiga, Brilinta | $141 | $26,83736 claims |
| Lilly USA, LLCTrulicity | $208 | $11,06912 claims |
| MerckDulera | $208 | $7,08821 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Sullivan
- Matthew TiefenbrunnSullivan$105K
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.